West Pharmaceutical Services reported quarterly EPS of $2.37, beating the Zacks Consensus Estimate of $2.08 (about +14%). EPS also rose from $1.84 a year ago, indicating clear year-over-year improvement. The earnings beat is likely supportive for the stock near term.
West Pharmaceutical Services reported quarterly EPS of $2.37, beating the Zacks Consensus Estimate of $2.08 (about +14%). EPS also rose from $1.84 a year ago, indicating clear year-over-year improvement. The earnings beat is likely supportive for the stock near term.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request DemoOverall Sentiment
moderately positive
Sentiment Score
0.45
Ticker Sentiment
